Federal award
ORTHO-CLINICAL DIAGNOSTICS INC
W81K0018P0301
Contract
Obligated and Ceiling
- Obligated (net)
- $766,325.61
- Ceiling (potential value, not spending)
- $766,325.61
- Current value
- $766,325.61
- Gross positive obligations
- $904,691.05
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ORTHO-CLINICAL DIAGNOSTICS INC · H7TKMH25XXJ4
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ORTHO-CLINICAL DIAGNOSTICS, INC · JG5JF2JQJ121
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0018P0301
- Award type code
- B
- Actions
- 18 · Jul 19, 2018 to Dec 6, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History18
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 6, 2023 | FY2024 | P00017 | C | −$23,865.56 | — |
| Aug 21, 2023 | FY2023 | P00016 | C | −$44,218.14 | — |
| Aug 1, 2023 | FY2023 | P00015 | D | −$43,189.47 | — |
| Jul 21, 2023 | FY2023 | P00014 | D | −$872.30 | — |
| Feb 2, 2023 | FY2023 | P00013 | D | −$26,214.99 | — |
| Oct 19, 2022 | FY2023 | P00012 | C | $199,038.40 | — |
| Sep 2, 2022 | FY2022 | P00011 | C | $0.00 | — |
| Nov 8, 2021 | FY2022 | P00010 | C | $189,527.72 | — |
| Aug 16, 2021 | FY2021 | P00009 | D | $0.00 | — |
| Jun 29, 2021 | FY2021 | P00008 | G | $0.00 | — |
| Nov 4, 2020 | FY2021 | P00007 | C | $180,490.65 | — |
| Oct 19, 2020 | FY2021 | P00006 | D | $0.00 | — |
| Apr 20, 2020 | FY2020 | P00005 | G | $0.00 | — |
| Nov 4, 2019 | FY2020 | P00004 | C | $171,880.94 | — |
| Aug 27, 2019 | FY2019 | P00003 | G | $0.00 | — |
| Apr 16, 2019 | FY2019 | P00002 | B | −$4.98 | — |
| Oct 25, 2018 | FY2019 | P00001 | C | $163,753.34 | — |
| Jul 19, 2018 | FY2018 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.